Literature DB >> 21856866

Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC.

Rahul Nahar1, Parham Ramezani-Rad, Maximilian Mossner, Cihangir Duy, Leandro Cerchietti, Huimin Geng, Sinisa Dovat, Hassan Jumaa, B Hilda Ye, Ari Melnick, Markus Müschen.   

Abstract

Initial cell surface expression of the pre-B cell receptor induces proliferation. After 2 to 5 divisions, however, large pre-BII (Fraction C') cells exit cell cycle to become resting, small pre-BII cells (Fraction D). The mechanism by which pre-BII cells exit cell cycle, however, is currently unclear. The checkpoint at the Fraction C'-D transition is critical for immunoglobulin light chain gene recombination and to prevent malignant transformation into acute lymphoblastic leukemia. Here we demonstrate that inducible activation of pre-B cell receptor signaling induces cell-cycle exit through up-regulation of the transcriptional repressor BCL6. Inducible activation of BCL6 downstream of the pre-B cell receptor results in transcriptional repression of MYC and CCND2. Hence, pre-B cell receptor-mediated activation of BCL6 limits pre-B cell proliferation and induces cellular quiescence at the small pre-BII (Fraction D) stage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856866      PMCID: PMC3204735          DOI: 10.1182/blood-2011-01-331181

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  B cell development pathways.

Authors:  R R Hardy; K Hayakawa
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Transcriptome analysis in primary B lymphoid precursors following induction of the pre-B cell receptor.

Authors:  Wolfgang Schuh; Silke Meister; Kai Herrmann; Harald Bradl; Hans-Martin Jäck
Journal:  Mol Immunol       Date:  2007-08-02       Impact factor: 4.407

3.  The expression of the Ig H chain repertoire in developing bone marrow B lineage cells.

Authors:  D J Decker; N E Boyle; J A Koziol; N R Klinman
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

4.  SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway.

Authors:  Sebastian Herzog; Eva Hug; Sonja Meixlsperger; Ji-Hye Paik; Ronald A DePinho; Michael Reth; Hassan Jumaa
Journal:  Nat Immunol       Date:  2008-06       Impact factor: 25.606

5.  Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.

Authors:  B H Ye; F Lista; F Lo Coco; D M Knowles; K Offit; R S Chaganti; R Dalla-Favera
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

6.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.

Authors:  Ryan T Phan; Riccardo Dalla-Favera
Journal:  Nature       Date:  2004-12-02       Impact factor: 49.962

7.  BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.

Authors:  Joji Nakayama; Mutsumi Yamamoto; Katsuhiko Hayashi; Hitoshi Satoh; Kenji Bundo; Masato Kubo; Ryo Goitsuka; Michael A Farrar; Daisuke Kitamura
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

8.  Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.

Authors:  Hassan Jumaa; Lukas Bossaller; Karina Portugal; Bettina Storch; Michael Lotz; Alexandra Flemming; Martin Schrappe; Ville Postila; Pekka Riikonen; Jukka Pelkonen; Charlotte M Niemeyer; Michael Reth
Journal:  Nature       Date:  2003-05-22       Impact factor: 49.962

9.  Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.

Authors:  Daniel Trageser; Ilaria Iacobucci; Rahul Nahar; Cihangir Duy; Gregor von Levetzow; Lars Klemm; Eugene Park; Wolfgang Schuh; Tanja Gruber; Sebastian Herzog; Yong-mi Kim; Wolf-Karsten Hofmann; Aihong Li; Clelia Tiziana Storlazzi; Hans-Martin Jäck; John Groffen; Giovanni Martinelli; Nora Heisterkamp; Hassan Jumaa; Markus Müschen
Journal:  J Exp Med       Date:  2009-07-20       Impact factor: 14.307

10.  Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells.

Authors:  Rogier Kersseboom; Sabine Middendorp; Gemma M Dingjan; Katarina Dahlenborg; Michael Reth; Hassan Jumaa; Rudolf W Hendriks
Journal:  J Exp Med       Date:  2003-06-30       Impact factor: 14.307

View more
  31 in total

Review 1.  Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia.

Authors:  Markus Müschen
Journal:  Blood       Date:  2015-04-15       Impact factor: 22.113

Review 2.  Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.

Authors:  Siba El Hussein; Kenna R M Shaw; Francisco Vega
Journal:  Mod Pathol       Date:  2020-07-03       Impact factor: 7.842

3.  E3 Ubiquitin Ligase Fbw7 Regulates the Survival of Mature B Cells.

Authors:  Parham Ramezani-Rad; Charlotte R Leung; John R Apgar; Robert C Rickert
Journal:  J Immunol       Date:  2020-01-31       Impact factor: 5.422

4.  Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.

Authors:  M Frank Erasmus; Ksenia Matlawska-Wasowska; Ichiko Kinjyo; Avanika Mahajan; Stuart S Winter; Li Xu; Michael Horowitz; Diane S Lidke; Bridget S Wilson
Journal:  Sci Signal       Date:  2016-11-29       Impact factor: 8.192

Review 5.  New insights into pre-BCR and BCR signalling with relevance to B cell malignancies.

Authors:  Robert C Rickert
Journal:  Nat Rev Immunol       Date:  2013-08       Impact factor: 53.106

6.  Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK.

Authors:  Ekaterina Kim; Christian Hurtz; Stefan Koehrer; Zhiqiang Wang; Sriram Balasubramanian; Betty Y Chang; Markus Müschen; R Eric Davis; Jan A Burger
Journal:  Blood       Date:  2016-12-28       Impact factor: 22.113

7.  Cutting edge: cell-autonomous control of IL-7 response revealed in a novel stage of precursor B cells.

Authors:  Gabriel J Sandoval; Daniel B Graham; Deepta Bhattacharya; Barry P Sleckman; Ramnik J Xavier; Wojciech Swat
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

8.  SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia.

Authors:  Parham Ramezani-Rad; Huimin Geng; Christian Hurtz; Lai N Chan; Zhengshan Chen; Hassan Jumaa; Ari Melnick; Elisabeth Paietta; William L Carroll; Cheryl L Willman; Véronique Lefebvre; Markus Müschen
Journal:  Blood       Date:  2012-11-14       Impact factor: 22.113

9.  The pre-BCR to the rescue: therapeutic targeting of pre-B cell ALL.

Authors:  Thomas Trimarchi; Iannis Aifantis
Journal:  Cancer Cell       Date:  2015-03-09       Impact factor: 31.743

10.  Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.

Authors:  Jesús Duque-Afonso; Jue Feng; Florian Scherer; Chiou-Hong Lin; Stephen H K Wong; Zhong Wang; Masayuki Iwasaki; Michael L Cleary
Journal:  J Clin Invest       Date:  2015-08-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.